{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3192, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to explain the drug discovery pipeline from patient cohort to manufacturing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/9", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-9", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to illustrate the transformation of biological targets into optimized drug candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/10", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-10", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process-flow visual to contrast discovery vs. optimization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/11", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-11", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "cover", "function": "front_matter", "notes": "The slide features the company logo and a stylized 'a' graphic.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/12", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-12", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "other", "function": "cite_precedent", "notes": "The slide highlights a specific Nature Biomedical Engineering paper as validation of the company's core technology approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/13", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-13", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to show the transition from parental mAb to optimized mAb via AI.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/14", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-14", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a technical methodology for biological data generation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/15", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-15", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "The slide includes a small schematic icon representing the scatter plot and a callout box emphasizing the necessity of high-quality data for AI training.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/16", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-16", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table outlines the experimental design for antibody optimization models, specifically highlighting the differences in sampling strategies and mutational loads.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/17", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-17", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide explains the methodology behind the dataset used for AI lead optimization, specifically focusing on the combinatorial space of amino acid mutations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/18", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-18", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "Includes scatter plots showing correlation and a bar chart comparing model performance metrics against experimental replicates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/19", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-19", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "The chart shows density vs -log10Kd, comparing design vs validation vs measured trastuzumab.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/20", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-20", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights the methodology of sampling sequence space and validating predictive models against measured binding affinity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/21", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-21", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "The chart compares High vs Low Fidelity models with and without pretraining across different training data sizes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/22", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-22", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide shows scatter plots for quadruple and quintuple mutants and a summary bar chart for performance metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/23", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-23", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a combination of diagrams and a summary box to explain the methodology of using AI to predict antibody naturalness.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/24", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-24", "loopMatches": [ { "to": 26, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "299a17ec-2bdc-4f4a-8f9c-f98f13d86ff5", "evidence": "The deck highlights the risks and challenges of current methods and the benefits of Absci's solution.", "position": 0, "objective": "Highlight the risks and challenges of current methods and the benefits of Absci's solution", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses box plots and bar charts to show statistical correlation between naturalness and clinical/developability outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/25", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-25", "loopMatches": [ { "to": 26, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "299a17ec-2bdc-4f4a-8f9c-f98f13d86ff5", "evidence": "The deck highlights the risks and challenges of current methods and the benefits of Absci's solution.", "position": 0, "objective": "Highlight the risks and challenges of current methods and the benefits of Absci's solution", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses box plots and density plots to demonstrate that higher naturalness correlates with better expression and lower mutational burden.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/26", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-26", "loopMatches": [ { "to": 26, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "299a17ec-2bdc-4f4a-8f9c-f98f13d86ff5", "evidence": "The deck highlights the risks and challenges of current methods and the benefits of Absci's solution.", "position": 0, "objective": "Highlight the risks and challenges of current methods and the benefits of Absci's solution", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "solution", "function": "present_solution", "notes": "The charts show the progression of antibody variants over generations, highlighting the improvement in ACE score and naturalness metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/27", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-27", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a process diagram to illustrate the 'in silico' lead optimization workflow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/28", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-28", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to show the integration of AI in drug development.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/29", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-29", "loopMatches": [ { "to": 29, "from": 6, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9ee18f27-0598-416a-8927-048571ff09f9", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 1, "objective": "Show how Absci's solution can accelerate the discovery and generation of optimized protein biologics", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 29, "from": 6, "beatId": "8717afca-670f-4c53-9154-841d8d01c54d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents Absci's AI-enabled platform and active learning cycle as a solution to the challenges of biologic drug discovery.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9d67-725f-975b-68e2ea1578ba", "docSlug": "df4019524c1d62b73cca6d59915e8eef", "documentTitle": "Absci | Investor Presentation Deck | 30 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "quote_slide", "function": "inspire_vision", "notes": "The slide uses a lightbulb icon as a metaphor for innovation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9d67-725f-975b-68e2ea1578ba/30", "deckHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba", "deckAnchorHref": "/decks/019de073-9d67-725f-975b-68e2ea1578ba#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/LgicWlr838avwb3vUz46ewqqIPTJbdCDfZdO3b1cihQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNDY5YjgyMjNmNmY4NmNiNWQ2YTFmMGE5OWNiY2U1Yy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/1", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/rwUQ9P4nFAivOjIUkXdGDBk-2pxIQS4F1GMq1CX5M2E/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNDY5YjgyMjNmNmY4NmNiNWQ2YTFmMGE5OWNiY2U1Yy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/Ormhpv2HFdFhbq7NYkb_9Kcvr0eI7LTSnmdxBLRTnyU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNDY5YjgyMjNmNmY4NmNiNWQ2YTFmMGE5OWNiY2U1Yy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/fOX4Jvn-p9tfwvnwia9-R_PopgJRFWDvK0tdMlQKVSc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNDY5YjgyMjNmNmY4NmNiNWQ2YTFmMGE5OWNiY2U1Yy9wMDAxLnBuZw" }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": "Includes a specific disclosure regarding Dr. Harvey Levy's role as a Principal Investigator and Consultant.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/2", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/3", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/4", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "present_framework", "notes": "The slide uses a Gantt-style bar chart to represent clinical trial phases for each drug program.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/5", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/6", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a hierarchical diagram to map the clinical manifestations of the disease.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/7", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "dfc95667-9e06-43c4-ab5b-f60c317fa5c8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 7-10 provide an overview of Classical HCU, its clinical severity, and current clinical guidelines", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "other", "function": "frame_problem", "notes": "The diagram illustrates the metabolic pathway and the specific block at the Cystathionine beta-synthase step.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/8", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "dfc95667-9e06-43c4-ab5b-f60c317fa5c8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 7-10 provide an overview of Classical HCU, its clinical severity, and current clinical guidelines", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "comparison_table", "function": "compare_peers", "notes": "The table contrasts clinical outcomes (Hcy levels, lens dislocation, IQ, thrombosis, mortality) between two patient cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/9", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "dfc95667-9e06-43c4-ab5b-f60c317fa5c8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 7-10 provide an overview of Classical HCU, its clinical severity, and current clinical guidelines", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "key_messages", "function": "establish_context", "notes": "Includes a citation of the specific clinical guidelines paper.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/10", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "dfc95667-9e06-43c4-ab5b-f60c317fa5c8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 7-10 provide an overview of Classical HCU, its clinical severity, and current clinical guidelines", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "Includes historical context of diagnostic methods (pre-NBS era).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/11", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-11", "loopMatches": [ { "to": 14, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "946aef3a-76bb-47e2-a4de-02631e3ad727", "evidence": "The deck emphasizes the burden of disease and limitations of current management", "position": 0, "objective": "Highlight the cost of inaction for Classical HCU patients", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 11, "beatId": "e2d18a2e-d898-4d6e-9bf1-62eefe35ed84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 11-14 highlight the diagnostic delay, risk of misdiagnosis, and current management limitations", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "comparison_table", "function": "diagnose_problem", "notes": "The slide uses a table to show symptom overlap (+) and absence (-) between two conditions, accompanied by a visual comparison of patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/12", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-12", "loopMatches": [ { "to": 14, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "946aef3a-76bb-47e2-a4de-02631e3ad727", "evidence": "The deck emphasizes the burden of disease and limitations of current management", "position": 0, "objective": "Highlight the cost of inaction for Classical HCU patients", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 11, "beatId": "e2d18a2e-d898-4d6e-9bf1-62eefe35ed84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 11-14 highlight the diagnostic delay, risk of misdiagnosis, and current management limitations", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide highlights the clinical consequences of missing HCU in newborn screening (NBS).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/13", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-13", "loopMatches": [ { "to": 14, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "946aef3a-76bb-47e2-a4de-02631e3ad727", "evidence": "The deck emphasizes the burden of disease and limitations of current management", "position": 0, "objective": "Highlight the cost of inaction for Classical HCU patients", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 11, "beatId": "e2d18a2e-d898-4d6e-9bf1-62eefe35ed84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 11-14 highlight the diagnostic delay, risk of misdiagnosis, and current management limitations", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "other", "function": "establish_context", "notes": "The slide displays various medical nutrition products used for HCU management.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/14", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-14", "loopMatches": [ { "to": 14, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "946aef3a-76bb-47e2-a4de-02631e3ad727", "evidence": "The deck emphasizes the burden of disease and limitations of current management", "position": 0, "objective": "Highlight the cost of inaction for Classical HCU patients", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 11, "beatId": "e2d18a2e-d898-4d6e-9bf1-62eefe35ed84", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 11-14 highlight the diagnostic delay, risk of misdiagnosis, and current management limitations", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "Includes a clinical photograph of two patients, likely illustrating physical manifestations or growth issues associated with the condition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/15", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "other", "function": "illustrate_case", "notes": "Case study format used to illustrate the consequences of poor disease management.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/16", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a list-based approach to describe the disease burden, paired with a visual column of key clinical manifestations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/17", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a simple problem-solution structure, identifying the clinical gap and the resulting need.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/18", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "closing_ask", "function": "closing_ask", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/19", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/20", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-20", "loopMatches": [ { "to": 24, "from": 20, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8d7561ed-879a-4cee-9208-d194f7670c57", "evidence": "The deck presents Pegtarviliase as a potential best-in-class treatment", "position": 1, "objective": "Introduce Pegtarviliase as a solution to address the needs of Classical HCU patients", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "5fa22bc5-87f2-4946-9705-fa014d063ae3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 20-24 introduce Pegtarviliase as a potential best-in-class treatment and provide an overview of its innovative approach", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a pie chart to show patient segmentation by B6 responsiveness and a timeline/number-line to show age of diagnosis, followed by key metrics on complication rates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/21", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-21", "loopMatches": [ { "to": 24, "from": 20, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8d7561ed-879a-4cee-9208-d194f7670c57", "evidence": "The deck presents Pegtarviliase as a potential best-in-class treatment", "position": 1, "objective": "Introduce Pegtarviliase as a solution to address the needs of Classical HCU patients", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "5fa22bc5-87f2-4946-9705-fa014d063ae3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 20-24 introduce Pegtarviliase as a potential best-in-class treatment and provide an overview of its innovative approach", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "pain_points", "function": "diagnose_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/22", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-22", "loopMatches": [ { "to": 24, "from": 20, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8d7561ed-879a-4cee-9208-d194f7670c57", "evidence": "The deck presents Pegtarviliase as a potential best-in-class treatment", "position": 1, "objective": "Introduce Pegtarviliase as a solution to address the needs of Classical HCU patients", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "5fa22bc5-87f2-4946-9705-fa014d063ae3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 20-24 introduce Pegtarviliase as a potential best-in-class treatment and provide an overview of its innovative approach", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to show the metabolic block (CBS deficiency) and the therapeutic intervention point.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/23", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-23", "loopMatches": [ { "to": 24, "from": 20, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8d7561ed-879a-4cee-9208-d194f7670c57", "evidence": "The deck presents Pegtarviliase as a potential best-in-class treatment", "position": 1, "objective": "Introduce Pegtarviliase as a solution to address the needs of Classical HCU patients", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "5fa22bc5-87f2-4946-9705-fa014d063ae3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 20-24 introduce Pegtarviliase as a potential best-in-class treatment and provide an overview of its innovative approach", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a biological process diagram to contrast normal intracellular metabolism with the therapeutic effect of the drug in the plasma.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/24", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-24", "loopMatches": [ { "to": 24, "from": 20, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "8d7561ed-879a-4cee-9208-d194f7670c57", "evidence": "The deck presents Pegtarviliase as a potential best-in-class treatment", "position": 1, "objective": "Introduce Pegtarviliase as a solution to address the needs of Classical HCU patients", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "5fa22bc5-87f2-4946-9705-fa014d063ae3", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 20-24 introduce Pegtarviliase as a potential best-in-class treatment and provide an overview of its innovative approach", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "roadmap", "function": "present_framework", "notes": "The slide uses a process flow diagram to represent clinical trial cohorts and study design.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/25", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/26", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/27", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9e32-71bd-acba-301a2d9cbf00", "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c", "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "cover", "function": "front_matter", "notes": "This is a standard corporate cover slide featuring the company logo and address.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/28", "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00", "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/hX_B5EGuW323xVHDGXuFyZYtjjWujm4LruyrDX5jHew/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNGIwOTUyODRiMDUwMTc3ZmVkYjliY2M4MDQ4ODNjZi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/1", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/kvW1aChOSrkqOf1ceNrCQs1vth2kkYsUnXX0KNci96g/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNGIwOTUyODRiMDUwMTc3ZmVkYjliY2M4MDQ4ODNjZi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/-j8bFTsrtoW_QDBAEKYtvLnYuWEhKTRTvBp2PBitUfU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNGIwOTUyODRiMDUwMTc3ZmVkYjliY2M4MDQ4ODNjZi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/VBBYlHYqyhFQTbM8yy884tGjeE8c9Bdv_13XElbIXB8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kNGIwOTUyODRiMDUwMTc3ZmVkYjliY2M4MDQ4ODNjZi9wMDAxLnBuZw" }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/2", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 3, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/3", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 4, "slideType": "cover", "function": "front_matter", "notes": "The slide uses a stylized logo for the ASSERT study.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/4", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 5, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart uses stacked bars to represent cumulative patient population growth associated with clinical trial programs (PEDFIC, ASSERT, BOLD).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/5", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 6, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a photo of a child with medical equipment to humanize the disease impact.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/6", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "09d6907a-aaa2-4e15-ac11-e54dd972bb17", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slide 6 describes Alagille Syndrome as a devastating disease", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 8, "from": 6, "beatId": "e380920f-15b5-408a-b604-73b836d960d5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 6-8 emphasize the severity of pruritus and sleep disturbances", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 7, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a standard randomized controlled trial (RCT) design for a pharmaceutical study.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/7", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "e380920f-15b5-408a-b604-73b836d960d5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 6-8 emphasize the severity of pruritus and sleep disturbances", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 8, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide includes a footer note regarding patient completion rates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/8", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "e380920f-15b5-408a-b604-73b836d960d5", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 6-8 emphasize the severity of pruritus and sleep disturbances", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 9, "slideType": "before_after", "function": "analyze_data", "notes": "Clinical trial data showing efficacy of Odevixibat (Bylvay) vs Placebo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/9", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-9", "loopMatches": [ { "to": 12, "from": 9, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "93296dcc-1d5a-42f1-ad7d-d28ccac68dc6", "evidence": "Slides 9-12 use before-after comparisons to demonstrate the efficacy of Bylvay", "position": 0, "objective": "Show the improvement in pruritus and sleep parameters", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "706e309a-1edf-406d-a385-6a9dfcf6cec7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 9-14 present Bylvay as a solution, highlighting its efficacy and safety profile", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-9ed2-75f5-b4c4-69324b7a8310", "docSlug": "d4b095284b050177fedb9bcc804883cf", "documentTitle": "Albireo Pharma | Results Presentation Deck | 18 slides", "authorId": "albireo-pharma", "authorName": "Albireo Pharma", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 10, "slideType": "before_after", "function": "analyze_data", "notes": "The chart displays LS Mean (95% CI) with p-value significance markers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-9ed2-75f5-b4c4-69324b7a8310/10", "deckHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310", "deckAnchorHref": "/decks/019de073-9ed2-75f5-b4c4-69324b7a8310#slide-10", "loopMatches": [ { "to": 12, "from": 9, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "93296dcc-1d5a-42f1-ad7d-d28ccac68dc6", "evidence": "Slides 9-12 use before-after comparisons to demonstrate the efficacy of Bylvay", "position": 0, "objective": "Show the improvement in pruritus and sleep parameters", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "706e309a-1edf-406d-a385-6a9dfcf6cec7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 9-14 present Bylvay as a solution, highlighting its efficacy and safety profile", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }